4P 025
Alternative Names: 4P-025Latest Information Update: 25 Nov 2022
At a glance
- Originator Delta 4
- Developer 4P-Pharma; Delta 4
- Class Hepatoprotectants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Liver disorders
Most Recent Events
- 01 Nov 2022 4P-Pharma and Delta 4 agree to co-develop therapeutics for Liver disorders (4P-Pharma pipeline, November 2022)
- 01 Nov 2022 Early research in Liver disorders in Austria (unspecified route) (4P-Pharma pipeline, November 2022)
- 01 Nov 2022 Early research in Liver disorders in France (unspecified route) (4P-Pharma pipeline, November 2022)